JAMP Pharma Group signs a landmark partnership agreement

JAMP Pharma Group signs a landmark partnership agreement

Canadian pharmaceutical company JAMP Pharma Group has signed an exclusive agreement with global speciality biopharmaceutical company Alvotech for the Canadian commercial rights to five biosimilars. The current market value of the branded sales for these five biosimilars is estimated to be exceeding $2 billion annually in Canada.  Read the Press Release

 

Member Forum

September 15, 2020
Angus Glen Golf Club
Markham, Ontario

MORE INFO

2019 Technology Boot Camp

November 20, 2019
Sheraton Toronto Airport Hotel & Conference Centre
Toronto

MORE INFO

Executive Conference

January 13 - 14, 2020
Montreal Airport Marriott In-Terminal Hotel
Dorval, QC

MORE INFO

Annual Conference

May 3 - 6, 2020
JW MARRIOTT NASHVILLE
Nashville, Tennessee

MORE INFO